Continuing anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy is associated with a lower likelihood of relapse of inflammatory bowel disease (IBD) in pregnant women and fewer ...
News-Medical.Net on MSN
Using placental growth factor to predict preeclampsia risk in pregnant women with sickle cell disease
In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring ...
Myo-inositol supplementation shows no significant benefits in preventing pregnancy complications for women with PCOS, according to a recent large-scale study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback